Atreca, Inc.

97 articles with Atreca, Inc.

• Atreca Nabs $35 Million To Advance Novel Cancer Immunotherapies

  8/17/2017

• Atreca And Dana-Farber Cancer Institute Establish Broad Cancer Immunotherapy R&D Collaboration

  5/31/2017

• Atreca Presents New Preclinical Findings For Novel Cancer Immunotherapy Platform At Molecular Medicine Tri-Conference 2017

  2/22/2017

• Atreca And A*STAR’s Genome Institute of Singapore Establish Joint Laboratory For Immuno-Oncology

  12/13/2016

• Atreca Presents Promising Findings From Lead Antibody Program At Society For Immunotherapy Of Cancer (SITC) Annual Meeting

  11/11/2016

• Atreca Describes Ebola Antibody Research Findings In Collaboration With Emory University

  10/26/2016

• Atreca Appoints Acclaimed Immunology Researcher Mark M. Davis, Ph.D., As A Technical Advisor

  8/10/2016

• Atreca Appoints Clinical Development Leader Lori Kunkel, M.D., As A Technical Advisor

  7/19/2016

• Atreca Appoints Leading Cancer Clinical Researcher Lawrence Fong, M.D., As A Technical Advisor

  6/22/2016

• Atreca Appoints Acclaimed Immunologist Lewis L. Lanier, Ph.D., As A Technical Advisor

  6/17/2016

• Atreca Announces Election Of Industry Leader David Lacey, M.D., To Its Board Of Directors

  6/7/2016

• Atreca To Present At The Jefferies 2016 Global Healthcare Conference

  6/1/2016

• Atreca Expands Leadership Team, Appoints Accomplished Cancer Immunotherapy Researcher And Drug Developer Norman M. Greenberg, Ph.D., As Chief Scientific Officer

  5/2/2016

• Atreca Announces Presentation Of Preclinical Data For Antibody Discovery Program

  3/31/2016

• Atreca Announces Presentation Of Preclinical Data For Cancer Immunotherapy Program

  3/14/2016

• Atreca Expands Leadership Team, Appoints Industry Leader Susan Berland As Executive Vice President And Chief Financial Officer

  2/16/2016

• Atreca To Present At The 18th Annual BIO CEO & Investor Conference

  2/5/2016